Gene therapy for hemophilia is ushering in a transformative era for patients grappling with this challenging bleeding disorder.By targeting the genetic causes of hemophilia, therapies like Hemgenix may offer unprecedented benefits, eliminating the need for traditional, frequent injections of clotting factors.